Ex vivo generated polyomavirus-specific T-cells

polyomavirus-specific T-cell therapy · NINDS (National Institute of Neurological Disorders and Stroke)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ex vivo generated polyomavirus-specific T-cells, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells [EARLY_Phase 1]

See pricing